Produktbild: Artificial Intelligence and Computational Approaches in Drug Discovery and Development
Band 43 Neu

Artificial Intelligence and Computational Approaches in Drug Discovery and Development

213,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

28.10.2026

Abbildungen

XII, 313 p. 93 illus., 83 illus. in color.

Herausgeber

Samir Chtita

Verlag

Springer

Seitenzahl

313

Maße (B/H)

15,5/23,5 cm

Sprache

Englisch

ISBN

978-3-032-28693-2

Beschreibung

Portrait

Samir CHTITA is a professor in the Department of Chemistry at the Faculty of Sciences Ben M’Sik, Hassan II University of Casablanca, Morocco. His research specializes in computational drug discovery, including QSAR/QSPR modeling, molecular docking, molecular dynamics, DFT calculations, and AI-based virtual screening. He has authored more than 200 peer-reviewed publications in high-impact journals in the fields of cheminformatics and molecular modeling. His recent work focuses on integrating artificial intelligence and machine learning to predict pharmacokinetic properties and bioactivities of drug-like molecules. Prof. CHTITA ranks among the top 2% most cited scientists globally (Stanford University classification).

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

28.10.2026

Abbildungen

XII, 313 p. 93 illus., 83 illus. in color.

Herausgeber

Samir Chtita

Verlag

Springer

Seitenzahl

313

Maße (B/H)

15,5/23,5 cm

Sprache

Englisch

ISBN

978-3-032-28693-2

Herstelleradresse

Springer International Publishing AG
Gewerbestr. 11
6330 Cham
Schweiz
Url: www.springer.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Artificial Intelligence and Computational Approaches in Drug Discovery and Development
  • Implementing a process-oriented "Fab Lab" model for AI in pharmaceutical sciences: Challenges and future directions.- Integration of AI and traditional computational methods in drug discovery.- Generative AI models for novel compound design.- Big data and data management for AI applications in pharmaceutical sciences.- Deep learning in molecular modeling: Advances and applications.- Drug repositioning strategies for viral diseases using AI.- DFT-Based study of natural compounds targeting Alzheimer’s disease.- New drug design targeting Alzheimer’s disease using AI approaches.- QSAR-Based virtual screening for Alzheimer’s therapeutics.- Molecular docking and dynamics of antidiabetic agents.- In-silico exploration of antidiabetic compounds from medicinal plants.- Computational approaches in cancer drug discovery.- Molecular modeling for cosmetic ingredient design.- AI and ML models against bacterial infections.